U.S. Neuropathic Pain Treatment Market
U.S. NEUROPATHIC PAIN TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)
U.S. Neuropathic Pain Treatment Market, By Drug Type (Pain Relievers (NSAIDS, Opioids (Tramadol, Oxycodone, and Others)), Anti-seizure Medications (Gabapentin, Pregabalin, and Others), Topical Treatments, Antidepressants (Duloxetine, Amitriptyline, Escitalopram, and Others), and Others), By Indication (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
- Published In: 31 Mar, 2026
- Code: CMI5429
- Page number: 155
- Formats: Excel and PDF
- Industry: Pharmaceutical
-
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033
Table of Contents (Version-2026)
Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Pipeline Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
U.S. Neuropathic Pain Treatment Market, By Drug Type, 2020 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
- Pain Relievers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- NSAIDS
- Opioids
- Tramadol
- Oxycodone
- Others
- Anti-seizure Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Gabapentin
- Pregabalin
- Others
- Topical Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Duloxetine
- Amitriptyline
- Escitalopram
- Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
U.S. Neuropathic Pain Treatment Market, By Indication, 2020 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
- Diabetic Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Chemotherapy-induced Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Idiopathic Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
U.S. Neuropathic Pain Treatment Market, By Distribution Channel, 2020 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (USD Mn)
Competitive Landscape
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Dr Reddy’s Laboratories Ltd.
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Cipla Inc.
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Averitas Pharma, Inc.
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- NeuroBo Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- LEXICON PHARMACEUTICALS, INC.
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Asahi Kasei Corporation
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Vertex Pharmaceuticals Incorporated
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
- Biogen
- Company Overview
- Product Portfolio
- SWOT Analysis
- Key Highlights
- Financial Overview
- Market Strategies
*Browse 18 market data tables and 21 figures on “Neuropathic Pain Treatment Market” – U.S. Forecast to 2033.
-
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
